Improving medicines value for money in the NHS and the role of biosimilars - assessing progress so far

Godman, Brian (2021) Improving medicines value for money in the NHS and the role of biosimilars - assessing progress so far. In: Westminster Health Forum policy conference, 2021-04-29 - 2021-04-29, Held Online.

[thumbnail of Godman-WHF-2021-Improving-medicines-value-for-money-in-the-NHS]
Preview
Text (Godman-WHF-2021-Improving-medicines-value-for-money-in-the-NHS)
Godman_WHF_2021_Improving_medicines_value_for_money_in_the_NHS.pdf
Accepted Author Manuscript

Download (710kB)| Preview

    Abstract

    Biosimilars are essential to help contain medicine costs and treat patients well with biologicals.